PYFA
vs
J
Jakarta Composite Index
PYFA
Over the past 12 months, PYFA has significantly outperformed Jakarta Composite Index, delivering a return of +145% compared to the Jakarta Composite Index's +19% growth.
Stocks Performance
PYFA vs Jakarta Composite Index
Performance Gap
PYFA vs Jakarta Composite Index
Performance By Year
PYFA vs Jakarta Composite Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
